Funding Details
- Awarder
- Inbox
- Date Award
- May 20, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Founders
- J.Robert Coleman, PhD, MBA
- Company Description
- HERVolution Therapeutics is a dark genome-focused biotechnology company providing new human endogenous retrovirus (HERV)-targeted immunotherapies to address diseases of aging. With its proprietary engineering approaches, it has rationally redesigned HERV-antigens to yield a new class of highly immunogenic antigens to address cancer, metabolic, and other aging-related diseases.
- Market
- Healthcare
- Location
-
Copenhagen,
Denmark
- Coinvestors
- Serum Institute of India, European Innovation Council Fund
Links